Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review

By Mazziotti Gherardo   Giustina Andrea  

Pituitary, Vol. 13, Iss. 1, 2010-03 ,pp. : 60-67

Springer Publishing Company

Access to resources Recommend Favorite

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel^® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

By Melmed Shlomo   Cook David   Schopohl Jochen   Goth Miklos   Lam Karen   Marek Josef  

Pituitary, Vol. 13, Iss. 1, 2010-03 ,pp. : 18-28

Springer Publishing Company

Access to resources Recommend Favorite

Griseofulvin: A potential addition to anti-Crohn's disease armamentarium

By Namazi M. R.  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 2, 2005-02 ,pp. : 244-245

Informa Healthcare

Access to resources Recommend Favorite

Canagliflozin : A New Hope in the Antidiabetic Armamentarium

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 8, Iss. 3, 2013-12 ,pp. : 216-220

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Acromegaly: Future

By Donangelo Ines   Melmed Shlomo  

Endocrine Journal, Vol. 28, Iss. 1, 2005-10 ,pp. : 123-128

Humana Press, Inc

Access to resources Recommend Favorite